Compare MLYS & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLYS | TENB |
|---|---|---|
| Founded | 2019 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | 2023 | 2018 |
| Metric | MLYS | TENB |
|---|---|---|
| Price | $37.07 | $24.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 17 |
| Target Price | ★ $47.33 | $39.25 |
| AVG Volume (30 Days) | ★ 1.5M | 1.5M |
| Earning Date | 02-11-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $974,603,000.00 |
| Revenue This Year | N/A | $12.22 |
| Revenue Next Year | N/A | $7.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.05 |
| 52 Week Low | $8.24 | $23.96 |
| 52 Week High | $47.65 | $45.45 |
| Indicator | MLYS | TENB |
|---|---|---|
| Relative Strength Index (RSI) | 43.16 | 28.54 |
| Support Level | $36.50 | $23.97 |
| Resistance Level | $38.23 | $25.18 |
| Average True Range (ATR) | 1.68 | 0.59 |
| MACD | 0.09 | -0.10 |
| Stochastic Oscillator | 41.96 | 4.73 |
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.